Improving the Value of Costly Genetic Reference Laboratory Testing With Active Utilization Management

被引:44
|
作者
Dickerson, Jane A. [1 ,3 ]
Cole, Bonnie [1 ,4 ]
Conta, Jessie H. [1 ]
Wellner, Monica [1 ]
Wallace, Stephanie E. [2 ,5 ]
Jack, Rhona M. [1 ,3 ]
Rutledge, Joe [1 ,3 ]
Astion, Michael L. [1 ,3 ]
机构
[1] Seattle Childrens Hosp, Dept Labs, Seattle, WA 98105 USA
[2] Seattle Childrens Hosp, Div Gen Med, Seattle, WA 98105 USA
[3] Univ Washington, Dept Lab Med, Seattle, WA 98105 USA
[4] Univ Washington, Dept Pathol, Seattle, WA 98105 USA
[5] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA
关键词
D O I
10.5858/arpa.2012-0726-OA
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Context.-Tests that are performed outside of the ordering institution, send-out tests, represent an area of risk to patients because of complexity associated with sending tests out. Risks related to send-out tests include increased number of handoffs, ordering the wrong or unnecessary test, specimen delays, data entry errors, preventable delays in reporting and acknowledging results, and excess financial liability. Many of the most expensive and most misunderstood tests are send-out genetic tests. Objective.-To design and develop an active utilization management program to reduce the risk to patients and improve value of genetic send-out tests. Design.-Send-out test requests that met defined criteria were reviewed by a rotating team of doctoral-level consultants and a genetic counselor in a pediatric tertiary care center. Results.-Two hundred fifty-one cases were reviewed during an 8-month period. After review, nearly one-quarter of genetic test requests were modified in the downward direction, saving a total of 2% of the entire send-out bill and 19% of the test requests under management. Ultimately, these savings were passed on to patients. Conclusions.-Implementing an active utilization strategy for expensive send-out tests can be achieved with minimal technical resources and results in improved value of testing to patients.
引用
收藏
页码:110 / 113
页数:4
相关论文
共 48 条
  • [41] Evaluating patients with autoimmune hemolytic anemia in the transfusion service and immunohematology reference laboratory: pretransfusion testing challenges and best transfusion-management strategies
    Johnson, Susan T.
    Puca, Kathleen E.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2022, (01) : 96 - 104
  • [42] Towards enhanced management and control of Buruli ulcer disease in Togo 2007-2013: implementation of active case finding and a national reference laboratory
    Beissner, M.
    Piten, E.
    Badziklou, K.
    Maman, I.
    Huber, K. L.
    Wiedemann, F. X.
    Kobara, B.
    Herbinger, K. -H.
    Nitschke, J.
    Kere, A. B.
    Loescher, T.
    Bretzel, G.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2013, 18 : 76 - 77
  • [43] Optimizing the delivery of genetic and advanced diagnostic testing in the province of Ontario: challenges and implications for laboratory technology assessment and management in decentralized healthcare systems
    Husereau, Don
    Sullivan, Terrence
    Feilotter, Harriet E.
    Gomes, Marcio M.
    Juergens, Rosalyn
    Sheffield, Brandon S.
    Kassam, Shaqil
    Stockley, Tracy L.
    Jacobs, Philip
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 993 - 1004
  • [44] Proficiency testing for total mercury in oyster with a metrologically traceable reference value from isotope dilution mass spectrometry: implications on laboratory practices using mercury analyzers
    Hwijin Kim
    Euijin Hwang
    Jwahaeng Park
    Sung Woo Heo
    Yong-Hyeon Yim
    Youngran Lim
    Myung Chul Lim
    Jong Wha Lee
    Kyoung-Seok Lee
    Accreditation and Quality Assurance, 2019, 24 : 253 - 261
  • [45] Proficiency testing for total mercury in oyster with a metrologically traceable reference value from isotope dilution mass spectrometry: implications on laboratory practices using mercury analyzers
    Kim, Hwijin
    Hwang, Euijin
    Park, Jwahaeng
    Heo, Sung Woo
    Yim, Yong-Hyeon
    Lim, Youngran
    Lim, Myung Chul
    Lee, Jong Wha
    Lee, Kyoung-Seok
    ACCREDITATION AND QUALITY ASSURANCE, 2019, 24 (04) : 253 - 261
  • [46] TIME INTERVAL BETWEEN SPERM PROCESSING AND INTRACYTOPLASMIC SPERM INJECTION (ICSI) OUTCOMES IN PREIMPLANTATION GENETIC TESTING CYCLES (PGT-A): IMPLICATIONS FOR LABORATORY MANAGEMENT.
    Hernandez-Nieto, Carlos
    Mejia-Fernandez, Loreli
    Alkon-Meadows, Tamar
    Lee, Joseph A.
    Slifkin, Richard E.
    Bar-Chama, Natan
    Copperman, Alan B.
    Mukherjee, Tanmoy
    FERTILITY AND STERILITY, 2024, 122 (04) : E179 - E179
  • [47] IMProving care After inherited Cancer Testing (IMPACT) study: protocol of a randomized trial evaluating the efficacy of two interventions designed to improve cancer risk management and family communication of genetic test results
    Deborah Cragun
    Jason Beckstead
    Meagan Farmer
    Gillian Hooker
    Marleah Dean
    Ellen Matloff
    Sonya Reid
    Ann Tezak
    Anne Weidner
    Jennifer G. Whisenant
    Tuya Pal
    BMC Cancer, 21
  • [48] IMProving care After inherited Cancer Testing (IMPACT) study: protocol of a randomized trial evaluating the efficacy of two interventions designed to improve cancer risk management and family communication of genetic test results
    Cragun, Deborah
    Beckstead, Jason
    Farmer, Meagan
    Hooker, Gillian
    Dean, Marleah
    Matloff, Ellen
    Reid, Sonya
    Tezak, Ann
    Weidner, Anne
    Whisenant, Jennifer G.
    Pal, Tuya
    BMC CANCER, 2021, 21 (01)